Literature DB >> 8483847

Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

H Harashima1, K Sakata, H Kiwada.   

Abstract

Opsonins play a role in the hepatic uptake of particles such as bacteria, lipid emulsion, and liposomes. The objective of this study was to distinguish between opsonin depletion and uptake saturation in the dose-dependent hepatic uptake of liposomes. The uptake of opsonized and unopsonized liposomes was determined in the isolated perfused liver. Serum (2.9 mL) was required to opsonize 1 mumol liposomes fully, indicating that a rat (250 g with 10 mL of serum) can opsonize 3.5 mumol liposomes. Next the dose effect on hepatic uptake of opsonized and unopsonized liposomes was examined. Saturation of uptake was found only for the opsonized liposomes. On the other hand, the hepatic uptake clearance decreased dose dependently from 4.31 to 0.79 (mL/min), with increasing doses from 0.075 to 17 mumol/250 g, respectively, after i.v. administration. Thus, the decrease in the hepatic uptake clearance at the medium dose was due to the saturation of uptake alone, and at the high dose it was due to opsonin depletion as well. These results show that the saturation of liposomal uptake in the liver and the depletion of opsonins occurred at different liposome dosage levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483847     DOI: 10.1023/a:1018918623658

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Non-Michaelis-Menten type hepatic uptake of liposomes in the rat.

Authors:  H Harashima; Y Kume; C Yamane; H Kiwada
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

2.  Effects of dose and vesicle size on the pharmacokinetics of liposomes.

Authors:  Y Sato; H Kiwada; Y Kato
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

3.  The role of an alpha2-macroglobulin of rat serum in the phagocytosis of colloidal particles.

Authors:  J Molnar; S McLain; C Allen; H Laga; A Gara; F Gelder
Journal:  Biochim Biophys Acta       Date:  1977-07-22

4.  The effect of blood on the uptake of liposomal lipid by perfused rat liver.

Authors:  A R Nicholas; M N Jones
Journal:  Biochim Biophys Acta       Date:  1991-05-24

5.  Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

Authors:  K Funato; R Yoda; H Kiwada
Journal:  Biochim Biophys Acta       Date:  1992-01-31

6.  Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.

Authors:  T M Allen; J M Everest
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

7.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Differential uptake of liposomes varying in size and lipid composition by parenchymal and kupffer cells of mouse liver.

Authors:  Y E Rahman; E A Cerny; K R Patel; E H Lau; B J Wright
Journal:  Life Sci       Date:  1982-11-08       Impact factor: 5.037

9.  Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver.

Authors:  P L Beaumier; K J Hwang
Journal:  Biochim Biophys Acta       Date:  1983-05-26

10.  Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes.

Authors:  S M Moghimi; H M Patel
Journal:  Biochim Biophys Acta       Date:  1989-09-18
View more
  6 in total

1.  Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes.

Authors:  H Harashima; K Sakata; K Funato; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

2.  Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.

Authors:  R M Fielding; L Moon-McDermott; R O Lewis; M J Horner
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

3.  Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Authors:  A Adedoyin; J F Bernardo; C E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

4.  Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

Authors:  H Harashima; C Yamane; Y Kume; H Kiwada
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

5.  Pharmacokinetics of iopromide liposomes in rabbits.

Authors:  G Schuhmann-Giampieri; J Leike; A Sachse; W Krause
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

Review 6.  Efficient hepatic delivery of drugs: novel strategies and their significance.

Authors:  Nidhi Mishra; Narayan Prasad Yadav; Vineet Kumar Rai; Priyam Sinha; Kuldeep Singh Yadav; Sanyog Jain; Sumit Arora
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.